Pilot Test of Patient Decision Aid for Opioid Use Disorder

Completed · Not applicable

Conditions studied: Opioid Use Disorder

In brief

The aims of the current study phase (R21) are: Aim 1. Develop a patient decision aid (PtDA-MAT) by incorporating best available scientific evidence on MAT as well as feedback from patients and clinical providers related to clinical priorities, perceived utility, and acceptability; Aim 2. Conduct pilot testing of the PtDA-MAT in an iterative process guided by an expert panel and involving key stakeholders (e.g., patients, physicians, policymakers) and field-testing.

Key facts

Study ID

NCT03394261

Run by

University of California, Los Angeles

People needed

72

Starts

2018-06-14

Expected to finish

2018-12-21

Last updated by the study team

2020-11-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Opioid Use Disorder diagnosis and agreement to follow study procedures (including permission to share medical records and other administrative records)

You may not qualify if…

• Significant or unstable medical or psychiatric illness that may interfere with study participation

Where it is running

• Tarzana Treatment Centers, Inc. — Tarzana, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.